Noom Med
Go Micro for Big Results
Medical weight loss arm of Noom offering GLP-1 medications alongside their psychology-based behavioral coaching platform with an industry-first taper-off guarantee.
Medications Available
Pros
- Integration with Noom behavioral coaching platform
- Low-dose/microdose options available
- Taper-off guarantee for sustainable approach
- Both compounded and brand-name options
- Psychology-based weight loss approach
Cons
- Compounded medications not FDA-approved
- Pricing can be confusing with multiple tiers
- Best value requires Noom ecosystem
- Eli Lilly ended partnership (no longer has Zepbound access)
Compare Noom Med With
See how Noom Med stacks up against other providers
How Noom Med Ranks
See where Noom Med places in our expert rankings
About Noom Med
Noom Med is the medical weight loss arm of Noom, launched in 2024 in New York, NY. They offer GLP-1 medications alongside Noom’s renowned psychology-based behavioral coaching platform. Their industry-first taper-off guarantee helps patients transition to sustainable weight maintenance.
How It Works
- Assessment - Complete Noom health evaluation
- Provider Consultation - Async consultation with clinicians
- Choose Your Plan - Select from low-dose, full-dose, or brand-name
- Behavioral Integration - Access Noom’s coaching platform
Pricing (February 2026)
| Plan | Price | Notes |
|---|---|---|
| Branded Medications Plan - First Month | $69 | Ozempic, Wegovy (medication NOT included) |
| Branded Medications Plan - Ongoing | $99/mo ($297/3mo) | Medication NOT included; additional $500-$1,000+/mo |
| GLP-1Rx Plan (Compounded) - First 21 Days | $149 | Compounded semaglutide INCLUDED |
| GLP-1Rx Plan (Compounded) - Ongoing | $279/mo | All-inclusive with medication |
| Microdose GLP-1 Program - First Month | $99-119 | Designed for lower doses |
| Microdose GLP-1 Program - Ongoing | $199/mo | Gentle, affordable approach |
| Weight Loss Pill Plan (Metformin) - First 21 Days | $29 | Medication included |
| Weight Loss Pill Plan - Ongoing | $89/mo | Medication included |
Important: Eli Lilly ended its partnership with Noom in late 2025 after Noom refused to stop selling compounded GLP-1s. Noom no longer has access to LillyDirect pricing for Zepbound/tirzepatide.
Who Is This Best For?
- Existing Noom users seeking medication support
- Patients interested in psychology-based weight loss
- Those wanting a sustainable taper-off approach
- People who prefer low-dose/microdose options
The Bottom Line
Noom Med combines GLP-1 medications with their proven behavioral coaching platform. The taper-off guarantee is unique in the industry, supporting sustainable weight maintenance beyond medication.
Last updated: February 2026
Last verified: February 2026
Ready to try Noom Med?
Compare with other providers or visit their website to get started.